<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7827">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03005041</url>
  </required_header>
  <id_info>
    <org_study_id>205067</org_study_id>
    <nct_id>NCT03005041</nct_id>
  </id_info>
  <brief_title>Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects</brief_title>
  <official_title>A Clinical Study Evaluating the Consumer Perception of an Experimental Mouthwash Formulation After a Single Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the consumer perception of an experimental
      mouthwash formulation in population with dry mouth
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Response to Post-Product use questionnaires 1 (PPUQ); Question No.1</measure>
    <time_frame>Within 2 minutes post product use</time_frame>
    <description>Participants will answer the following question, Q1: how much do you agree or disagree with the following statements about this product, having used it? &quot;This product is gentle&quot;: Disagree strongly, Disagree, Neither agree nor disagree, Agree, or Agree strongly.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Response to Post-Product use questionnaires 1 Question No. 3-7</measure>
    <time_frame>Within 2 minutes post product use</time_frame>
    <description>Which of the following statements best describes how much you liked the product overall? Liked it extremely, Liked it very much, Liked it somewhat, Liked it slightly, Did not like it that much, Did not like it at all. Q 4: Which of the following statements best describes how much you liked the OVERALL FLAVOR of the rinse? Liked it extremely, Liked it very much, Liked it somewhat, Liked it slightly, Did not like it that much, Did not like it at all. Q 5: How you would rate the FLAVOR INTENSITY of the Oral Rinse? Strongest flavour imaginable, Very strong, Strong, Moderate, Weak, Barely detectable, No flavour at all. Q 6: Did you experience any of the following sensations in your mouth and how strong was the sensation? moisturizing, soothing, refreshing, tingling, numbing, burning, or drying out. Participants who select &quot;None&quot;for a particular sensation would not complete Q 7 for that sensation: When did you experience the sensations in your mouth? Initially, During use, or After use.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events (AE)</measure>
    <time_frame>Up to 12 days</time_frame>
    <description>An AE is any untoward medical occurrence in a participants or clinical investigation participant, temporally associated with the use of an investigational or washout product, whether or not considered related to the investigational or washout product.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response to Product Performance Attribute Questionnaire (PPAQ)</measure>
    <time_frame>Within 5 minutes post product use</time_frame>
    <description>Participants will rate on a scale of 1 to 5 (1=Poor, 2= Fair, 3= Good, 4= Very good, 5= Excellent) each of following as they apply: 1. Having an immediate dry mouth relief, 2. Having an immediate lubricating effect, 3. Having an immediate moisturizing effect.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response to Post-Product use questionnaires 2</measure>
    <time_frame>Within 30 ± 5 minutes post product use</time_frame>
    <description>Participants will answer the following questions; Q1: Are you experiencing any of the following sensations in your mouth and how strong is the sensation? moisturizing, soothing, refreshing, tingling, numbing, burning, or drying out . Q2: Would you continue use of the product? (Yes or No)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Xerostomia</condition>
  <arm_group>
    <arm_group_label>Test Product 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will rinse their mouth with 15 mL of the product swishing for 30 seconds.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Product 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will rinse their mouth with 15 mL of the water swishing for 30 seconds. Participants then spit out the water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biotene mouthwash</intervention_name>
    <description>Participants will rinse their mouth with 15 mL of Biotene mouthwash swishing for 30 seconds.</description>
    <arm_group_label>Test Product 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bottled mineral water</intervention_name>
    <description>Participants will rinse their mouth with 15 mL of the water swishing for 30 seconds.</description>
    <arm_group_label>Test Product 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Demonstrates understanding of the study procedures, restrictions and willingness to
             participate as evidenced by voluntary written informed consent and has received a
             signed and dated copy of the informed consent form

          -  Aged 18 - 84 years inclusive

          -  Good general and mental health with, in the opinion of the investigator or medically
             qualified designee no clinically significant and relevant abnormalities in medical
             history or upon oral examination

          -  Participant reports having a feeling of a dry mouth according to the Dry Mouth
             Screening Questionnaire (DMSQ) (Subject must answer at least 2 out of the 4 questions
             with 'agree a little', 'agree' or 'strongly agree' at the Screening Visit (Visit 1).
             Participants with un-stimulated whole salivary flow rate of ≤0.1 ml/min at the
             Screening Visit (Visit 1).

          -  Participants with un-stimulated whole salivary flow rate of ≤0.1 ml/min ATH the
             Screening Visit (Visit 1).

          -  Understands and is willing, able and likely to comply with all study procedures and
             restrictions

        Exclusion Criteria:

          -  Women who are known to be pregnant or who are intending to become pregnant over the
             duration of the study or have a positive urine pregnancy test at the Screening Visit

          -  Women who are breast-feeding

          -  Participant is currently undergoing radiotherapy and/or chemotherapy treatment

          -  Any condition the investigator identifies that can confound the participant's ability
             to properly participate in the study e.g. Alzheimer's Disease

          -  Participant with untreated oral mucosal disease which in the opinion of the
             investigator could interfere with the study (e.g. current oral ulceration)

          -  Evidence of gross intra-oral neglect or need for extensive dental therapy

          -  Denture wearer (complete dentures)

          -  Participant not on stable doses of prescription systemic parasympathetic medications
             (e.g. Pilocarpine), for the treatment of the feeling of dry mouth

          -  Known or suspected intolerance or hypersensitivity to the study materials (or closely
             related compounds) or any of their stated ingredients

          -  Participation in another clinical study (including cosmetic studies) or receipt of an
             investigational drug within 14 days of the screening visit

          -  Previous participation in this study

          -  Recent history (within the last 1 year) of alcohol or other substance abuse

          -  An employee of the sponsor or the clinical study team or members of their immediate
             family. Students and employees of the Tufts University School of Dental Medicine not
             associated with the clinical trials team are eligible to participate. Students and
             employees will not be specifically targeted for enrollment

          -  Non-English speaking Participants will not be enrolled in the study. Participants
             must be able to read and write in English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 23, 2016</lastchanged_date>
  <firstreceived_date>August 30, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Xerostomia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
